[Paper Review] Evolutionary and Structural Constraints Define a Mutation-Resistant Catalytic Core in E. coli Serine Hydroxy methyltransferase (SHMT)

D. Surabhi Pandey, Dwipanjan Sanyal+3 more|arXiv (Cornell University)|Jan 2, 2026

Biochemical and Molecular Research0 citations

TL;DR

The paper uses a multi-scale computational framework to show that the catalytic core of E. coli SHMT is exceptionally conserved, tightly connected, and mutationally constrained, unlike peripheral regions, explaining its limited targeting by antibiotics.

ABSTRACT

Serine hydroxymethyltransferase is an essential enzyme in the Escherichia coli folate pathway, yet it has not been adopted as an antibacterial target, unlike DHFR, DHPS, or thymidylate synthase. To investigate this discrepancy, we applied a multi-scale computational framework that integrates large-scale sequence analysis of 1000 homologs, coevolutionary interaction mapping, structural community analysis, intrinsic disorder profiling, and adaptive fitness modelling. These analyses converge on a single conclusion: the catalytic core of SHMT forms an exceptionally conserved and tightly coupled structural unit. This region exhibits dense coevolution, strong intramolecular connectivity, minimal disorder, and extremely low mutational tolerance. Peripheral loops and termini, in contrast, are far more flexible. Relative to established folate-pathway antibiotic targets, SHMT active site is even more rigid and evolutionarily constrained. This extreme constraint may limit the emergence of resistance-compatible mutations, providing a plausible explanation for the absence of natural-product inhibitors. Fitness trajectory modelling supports this interpretation, showing that nearly all active-site residues tolerate only rare or neutral substitutions. Together, these findings identify SHMT as a structurally stable and evolutionarily restricted enzyme whose catalytic architecture is unusually protected. This makes SHMT an underexplored yet promising target for the rational design of next-generation antibacterial agents.

Motivation & Objective

• Motivate understanding why SHMT is not a common antibacterial target despite being essential in the folate pathway.
• Identify evolutionary and structural constraints that define SHMT's catalytic core.
• Assess mutational tolerance across SHMT to explain potential resistance emergence.
• Compare SHMT active-site rigidity to other folate-pathway targets to evaluate drug-design prospects.

Proposed method

• Integrates large-scale sequence analysis across ~1000 SHMT homologs.
• Applies coevolutionary interaction mapping to identify coupled residues.
• Uses structural community analysis and intrinsic disorder profiling.
• Implements adaptive fitness modelling to simulate mutational effects on function.
• Synthesizes results to characterize the catalytic core versus peripheral regions.

Experimental results

Research questions

• RQ1 What evolutionary and structural constraints define the SHMT catalytic core in E. coli?
• RQ2 How mutationally tolerant is the SHMT active site compared with peripheral regions?
• RQ3 Is SHMT more evolutionarily constrained and rigid than other folate-pathway targets, and what are the implications for drug design?

Key findings

• The catalytic core is exceptionally conserved and tightly coupled structurally.
• There is dense coevolution and strong intramolecular connectivity within the core.
• The catalytic core exhibits minimal disorder and extremely low mutational tolerance.
• Peripheral loops and termini are more flexible than the core.
• Relative to other folate-pathway targets, SHMT active site is more rigid and evolutionarily constrained.
• Fitness trajectory modelling suggests most active-site residues tolerate only rare or neutral substitutions.